When SASP was changed to 5-aminosalicylic acid (5-ASA), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
worsening of the dysesthesia
5-aminosalicylic acid
weakness
5-ASA
atrophy
5-ASA
weakness
5-aminosalicylic acid
gait disturbance
5-ASA
gait disturbance
5-aminosalicylic acid
worsening of the dysesthesia
5-ASA
atrophy
5-aminosalicylic acid